JOHN RANDOLPH MEDICAL CENTER — History
CCN 490020 | 3-year financial timeline | COVID resilience: 66/100
🛡️ Public data only — no PHI permitted on this instance.
$119M
Latest Revenue (FY2022)
+5.3%
Revenue CAGR (3yr)
20.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $107M | $143M | $119M | -16.5% | +5.3% |
| Operating Expenses | $91M | $114M | $95M | -17.2% | +1.9% |
| Operating Margin | 15.1% | 19.8% | 20.5% | +3.3% | +16.5% |
| Net Income | $16M | $28M | $24M | -13.8% | +22.7% |
| Licensed Beds | 107 | 107 | 107 | +0.0% | +0.0% |
| Total Patient Days | 17,504 | 22,143 | 18,224 | -17.7% | +2.0% |
| Medicare Day % | 38% | 33% | 31% | -6.7% | -9.5% |
| Medicaid Day % | 4% | 4% | 3% | -13.9% | -9.5% |
COVID Impact & Recovery
Resilience Score: 66/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +10.9% ($107M → $119M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+5.3%
This Hospital
+7.6%
State Avg
Latest Margin
20.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $125M | 23.2% |
| FY2024 (proj) | $131M | 25.9% |
| FY2025 (proj) | $137M | 28.6% |